Myriad Genetics buy melinda
Start price
10.09.17
/
50%
€29.42
Target price
22.01.18
€37.88
Performance (%)
18.73%
End price
22.01.18
€34.93
Summary
This prediction ended on 22.01.18 with a price of €34.93. The prediction had a final performance of 18.73%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Myriad Genetics | -7.759% | -7.759% | 3.883% | -5.477% |
iShares Core DAX® | -0.205% | 2.949% | 17.330% | 18.203% |
iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% | 56.281% |
iShares Nikkei 225® | -0.740% | -1.256% | 11.847% | 5.531% |
iShares S&P 500 | 0.267% | 3.240% | 29.308% | 46.371% |
Comments by melinda for this prediction
In the thread Myriad Genetics diskutieren
FOLGEN
$
Myriad Genetics, Inc.
GeneSight® Gezeigte Deutlich zu generalisierten Angststörung Ansprechen auf die Behandlung verbessern Statistisch gesehen und verringern Benzodiazepinkonsum
(Vom Mitglied beendet)